Citations

Clear

26 citation(s) found for "Schears, Gregory".

Extracorporeal Membrane Oxygenation Use in Acute Myocardial Infarction in the United States, 2000 to 2014
Vallabhajosyula, Saraschandra , Prasad, Abhiram , Bell, Malcolm R. , Sandhu, Gurpreet S. , Eleid, Mackram F. , Schears, Gregory J. , Stulak, John M., Jaffe, Allan S. , Holmes, David R. , Rihal, Charanjit S. , Barsness, Gregory W. , Dunlay, Shannon M. , Vallabhajosyula, Saraschandra , Prasad, Abhiram , Singh, Mandeep , Gersh, Bernard J. , Jaffe, Allan S. , Rihal, Charanjit S.

Mayo Clinic

Circulation: Heart Failure | December 12, 2019 | Volume: 12 | Issue: 12 | Pages: No page available

10.1161/circheartfailure.119.005929 | PMID 31826642 Get It

Background: Extracorporeal membrane oxygenation (ECMO) is increasingly used in acute myocardial infarction (AMI); however, there are limited large-scale national data. Methods: Using the National Inpatient Sample database from 2000 to 2014, a retrospective cohort of AMI utilizing ECMO was identified. Use of percutaneous coronary intervention, intra-aortic balloon pump, and percutaneous left ventricular assist device (LVAD) was also identified in this population. Outcomes of interest included temporal trends in utilization of ECMO alone and with concomitant procedures (percutaneous coronary intervention, intra-aortic balloon pump, and percutaneous LVAD), in-hospital mortality, and resource utilization. Results: In ≈9 million AMI admissions, ECMO was used in 2962 (<0.01%) and implanted a median of 1 day after admission. ECMO was used in 0.5% and 0.3% AMI admissions complicated by cardiogenic shock and cardiac arrest, respectively. ECMO was used more commonly in admissions that were younger, nonwhite, and with less comorbidity. ECMO use was 11× higher in 2014 as compared with 2000 (odds ratio, 11.37 [95% CI, 7.20–17.97]). Same-day percutaneous coronary intervention was performed in 23.1%; intra-aortic balloon pump/percutaneous LVAD was used in 57.9%, of which 30.3% were placed concomitantly. In-hospital mortality with ECMO was 59.2% overall but decreased from 100% (2000) to 45.1% (2014). Durable LVAD and cardiac transplantation were performed in 11.7% as an exit strategy. Of the hospital survivors, 40.8% were discharged to skilled nursing facilities. Older age, male sex, nonwhite race, and lower socioeconomic status were independently associated with higher in-hospital mortality with ECMO use. Conclusions: In AMI admissions, a steady increase was noted in the utilization of ECMO alone and with concomitant procedures (percutaneous coronary intervention, intra-aortic balloon pump, and percutaneous LVAD). In-hospital mortality remained high in AMI admissions treated with ECMO.
Practical Implementation of Failure Mode and Effects Analysis for Extracorporeal Membrane Oxygenation Activation
Nasim, Faria, Poterucha, Joseph T., Daniels, Lisa M. , Park, John G. , Seelhammer, Troy G. , Bohman, J. Kyle , Friedrich, Tammy, Blau, Caitlin, Elmer, Jennifer, Schears, Gregory J. , Bohman, John K., Friedrich, Tammy P, Blau, Caitlin L, Elmer, Jennifer L, Bohman, John K

Mayo Clinic

American Journal of Medical Quality | January 25, 2018 | Volume: 33 | Issue: 5 | Pages: 523-529

10.1177/1062860618754703 | PMID 29366330 Get It

Extracorporeal membrane oxygenation (ECMO) is used to treat severe hypoxemic respiratory failure and as a rescue therapy for patients with cardiopulmonary arrest within a narrow window of time. A failure modes and effects analysis (FMEA) was conducted to analyze the clinical and operational processes leading to delays in initiating ECMO. FMEA determined these highest-risk failure modes that were contributing to process failure: (1) ECMO candidacy not determined in time, (2) no or incomplete evaluation for ECMO prior to consult or arrest, (3) ECMO team not immediately available, and (4) cannulation not completed in time. When implemented collectively, a total of 4 interventions addressed more than 95% of the system failures. These interventions were (1) ECMO response pager held by a team required for decision, (2) distribution of institutionally defined inclusion/exclusion criteria, (3) educational training for clinicians consulting the ECMO team, and (4) establishment of a mobile ECMO insertion cart.
Granulocyte colony-stimulating factor significantly decreases density of hippocampal caspase 3-positive nuclei, thus ameliorating apoptosis-mediated damage, in a model of ischaemic neonatal brain injury†
Pastuszko, Peter , Schears, Gregory J. , Kubin, Joanna, Pastuszko, Anna, Wilson, David Franklin

Mayo Clinic

Interactive CardioVascular and Thoracic Surgery | August 2, 2017 | Volume: 25 | Issue: 4 | Pages: 600-605

10.1093/icvts/ivx047 | PMID 28962511 Get It

Adult extracorporeal membrane oxygenation: an international survey of transfusion and anticoagulation techniques
Esper, Stephen A. , Wallisch, William John , Waters, Jonathan H. , Triulzi, Darrell J., Schears, Gregory J. , Esper, S A , Welsby, Ian J , Subramaniam, Kathirvel , Levy, Jerrold H. , Hayanga, J.W. Awori

Mayo Clinic

Vox Sanguinis | May 3, 2017 | Volume: 112 | Issue: 5 | Pages: 443-452

10.1111/vox.12514 | PMID 28466601 Get It

Background and objectivesExtracorporeal membrane oxygenation (ECMO) is a method of life support for either isolated cardiac failure or respiratory failure, with or without cardiac failure. When used for hemodynamic support, the ECMO circuit presents a non‐endothelialized, artificial surface to blood inciting an inflammatory response which activates haemostatic pathways. Anticoagulation may complicate a pre‐existing coagulopathy and/or inadequate surgical hemostasis of varying severity. There is no standardized method to achieve and monitor anticoagulation or guide transfusion therapy during ECMO. We tested the hypothesis that institutions across the world conduct similar management of anticoagulation and transfusion during adult ECMO support.MethodsThis is a descriptive, self‐reporting cross‐sectional survey of anticoagulation and transfusion practice for patients age 18 or older on ECMO. This 38 multiple‐choice question survey was sent to 166 institutions, internationally, utilizing adult ECMO. About 32·4% (54) of institutions responded. Responses were anonymously collected. Descriptive analyses were calculated.ResultsOur findings indicate there appears to be a significant practice variation among institutions regarding anticoagulation and transfusion during adult ECMO support.DiscussionThe lack of standard practices among institutions may reflect a paucity of data regarding optimal anticoagulation and transfusion for patients requiring ECMO. Standardized protocols for anticoagulation and transfusion may help increase quality of care for and reduce morbidity, mortality and cost to patients and healthcare centres. Further study is required for standardized, high quality care.
Interpreting National Databases on Mechanical Circulatory Support
Vallabhajosyula, Saraschandra , Narayan, Aarti, Mankad, Sunil , Schears, Gregory J. , Jentzer, Jacob C. , Vallabhajosyula, Saraschandra

Mayo Clinic

Critical Care Medicine | April 15, 2017 | Volume: 45 | Issue: 5 | Pages: e532-e532

10.1097/ccm.0000000000002297 | PMID 28410319 Get It

Congenital diaphragmatic hernia: outcomes of neonates treated at Mayo Clinic with and without extracorporeal membrane oxygenation
Bojanić, Katarina , Woodbury, Jason M. , Cavalcante, Alexandre N. , Grizelj, Ruža , Asay, Garth F., Colby, Christopher E. , Carey, William A., Schears, Gregory J. , Schroeder, Darrell R. , Weingarten, Toby N. , Šprung, Juraj , Schroeder, Darrell

Mayo Clinic

Pediatric Anesthesia | February 17, 2017 | Volume: 27 | Issue: 3 | Pages: 314-321

10.1111/pan.13046 | PMID 28211131 Get It

SummaryBackgroundCongenital diaphragmatic hernia (CDH) is a rare anomaly with high mortality and long‐term comorbid conditions.AimsOur aim was to describe the presenting characteristics, treatment, and outcomes of consecutive patients with CDH treated at our institution.MethodsWe performed a retrospective cohort study and identified consecutive neonates treated for CDH from 2001 to 2015 at our institution. For all patients identified, we reviewed hospital and postdischarge data for neonatal, disease, and treatment characteristics. We determined hospital survival overall and also according to the presence of prenatal diagnosis, liver herniation into the chest (liver up), and the use of extracorporeal membrane oxygenation (ECMO) in addition to surgery. We evaluated postdischarge chronic conditions in patients with at least one year of follow‐up.ResultsThirty‐eight neonates were admitted for treatment during the study period. In three who were in extremis, life support was withdrawn. The other 35 underwent surgical repair, of whom eight received ECMO. The overall survival was 79% (30/38). Survival for those who had surgical correction of CDH but did not need ECMO was 89% (24/27); it was 75% (6/8) for those who received ECMO and had surgery. Hospital survival was lower for liver‐up vs liver‐down CDH (61% [11/18] vs 95% [19/20]; odds ratio, 0.08; 95% CI, 0.01–0.77; P = 0.01). Among survivors, the median duration of hospitalization was 31 (interquartile range, 20–73) days. Major chronic pulmonary and gastrointestinal disorders, failure to thrive, and neurodevelopmental delays were the most noted comorbid conditions after discharge, and all were more prevalent in those who required ECMO.ConclusionThe overall survival of neonates with CDH was 79%. Intrathoracic liver herniation was associated with more frequent use of ECMO and greater mortality. A substantial number of survivors, especially those who required ECMO, experienced chronic conditions after discharge.
Postcardiotomy ECMO Support after High-risk Operations in Adult Congenital Heart Disease
Acheampong, Benjamin , Johnson, Jonathan N. , Stulak, John M., Kushwaha, Sudhir S. , Daly, Richard C. , Haile, Dawit T. , Schears, Gregory J. , Dearani, Joseph A.

Mayo Clinic

Congenital Heart Disease | July 20, 2016 | Volume: 11 | Issue: 6 | Pages: 751-755

10.1111/chd.12396 | PMID 27436116 Get It

Fresh and Citrated Whole-Blood Specimens Can Produce Different Thromboelastography Results in Patients on Extracorporeal Membrane Oxygenation
Gilman, Elizabeth A. , Koch, Christopher D. , Santrach, Paula J., Schears, Gregory J. , Karon, Brad S.

Mayo Clinic

American Journal of Clinical Pathology | July 29, 2013 | Volume: 140 | Issue: 2 | Pages: 165-169

10.1309/ajcpyiq9jnnsen4q | PMID 23897250 Get It

Abstract Objectives: To compare thromboelastography (TEG) tracings obtained from fresh and citrated whole-blood samples in patients on extracorporeal membrane oxygenation (ECMO) or after cardiopulmonary bypass and in healthy volunteers. Methods: Samples of fresh and citrated whole blood were analyzed for 25 patients and 4 healthy volunteers. Thromboelastography analysis was performed in both plain and heparinase cups. Results: In 5 of 6 patients on ECMO, use of citrated samples resulted in apparent partial or complete heparin reversal. In TEG tracings from patients following cardiopulmonary bypass, there was a slight hypercoagulable appearance in the citrated sample. No differences were noted between fresh and citrated samples from healthy volunteers whose blood was spiked with heparin. Conclusions: In some patients on ECMO, use of samples collected in sodium citrate tubes for TEG analysis results in significant artifacts, which could lead to heparin overdosing in these patients.
Ultrasound for vascular access in pediatric patients
Schindler, Ehrenfried , Schears, Gregory J. , Hall, Stuart R., Yamamoto, Tomohiro

Mayo Clinic

Pediatric Anesthesia | September 12, 2012 | Volume: 22 | Issue: 10 | Pages: 1002-1007

10.1111/pan.12005 | PMID 22967159 Get It

SummaryObjectivesIn pediatric patients vascular access is often more difficult than in adults because of the smaller size of the vessels and the inability of the patient to cooperate without deep sedation or general anesthesia. Therefore Ultrasound has already become an invaluable tool for vascular access, but the full potential of ultrasound has yet to be fully realized. Improvements in image quality and a better understanding of optimal insertion techniques continue to help clinicians safely and efficiently place catheters with fewer complications.Methods and TechniqueThe probes used for the vascular access are mainly linear and convex type. Higher‐ frequency ultrasound provides a vivid image; however, the signals are remarkably attenuated. Therefore, the choice of the probe with appropriate frequency is essential. As blood vessels are relatively easily identified with ultrasound, ultrasound‐guided vascular access does not require as sharp images as ultrasound‐guided nerve block. For pediatric vascular access, the linear probe with 5–15 MHz, 2–5 cm depth is ideal and adequate for almost all cases. Ultrasound‐guided vascular access has two main approaches: ‘long‐axis’ or ‘in‐plane approach’ and ‘short‐axis’ or ‘transverse approach’. The long‐axis approach visualizes the vessel along the insertion pathway and is commonly used to monitor the entire approach of the needle into the vessel. The short‐axis approach is easier to show the positional relationship and depth of target vessels, but it is much harder to follow the needle tip within the tissues.ConclusionThe use of ‘real‐time’ ultrasound has been shown to increase first insertion success, reduce access time, have a higher overall success, and reduce arterial puncture. As the technology continues to improve the use of ultrasound will become as ubiquitous as the lines themselves.
Online Surveys: A Potential Weapon Against Clinician Non-Compliance
Schears, Gregory J.

Mayo Clinic

Journal of the Association for Vascular Access | April 23, 2012 | Volume: 17 | Issue: 1 | Pages: 38-41

10.2309/java.17-1-5 Get It

Abstract Over the last two decades, our understanding of the pathogenesis of central line associated blood steam infections has improved significantly. Also, increased attention has been focused on reducing healthcare worker exposure to infectious agents. Best practice protocols have been developed to eliminate unnecessary morbidity, mortality and costs associated with these infections and exposures. Adoption of these best practices has been incomplete and non-compliance is a major factor preventing our infectious complication rates from reaching zero. Getting at the root cause of noncompliance is complex. Online surveys are uniquely positioned to help understand the human factors contributing to non-compliance. This article reviews some of the pros and cons associated with the use of online surveys. Using several relevant recent examples, this article explores how these surveys can be used to identify those factors that create barriers to compliance. By better understanding all the issues involved with non-compliance, we will be able to create strategies and engineer products to improve best practice protocol compliance and reduce the human factor contribution to our patient's infectious complications.